Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Capper/Decapper

By Drug Discovery Trends Editor | March 18, 2010

Thermo Fisher Scientific Inc., the world leader in serving science, jointly introduced the new Capit-All IS Automated Capper/Decapper with The Automation Partnership. This robust, high-throughput instrument can de-cap or re-cap an entire rack of samples in less than ten seconds. Secure capping is ensured as each tube is individually sealed by its own separate clutch mechanism to the optimal torque, while all 96 caps are secured simultaneously for fast, quality capping. The incorporation of an automated drip tray and a vacuum extraction port reduce any risk of contamination.

The compact, benchtop Capit-All IS Automated Capper/Decapper is easily integrated with automated liquid handling instrumentation. Its intuitive design makes it easily operated by any laboratory personnel with the simple push of a button; no training is needed. Composed of specially molded parts, any possible distortion and damage to the caps after repeated use is prevented. As a result, the life span of the tubes and caps is significantly increased.

Stephen Guy, product manager, Bench top Cell Processing Systems, at The Automation Partnership commented, “The new Capit-All IS unit is compatible with Thermo Scientific Matrix or Thermo Scientific Nunc labware. Both models are highly reliable and have been tested to process one million samples to ensure uptime before service is required.” Kacey Wiley Pouliot, product manager, Sample Storage and Microplates at Thermo Fisher Scientific added, “With the ability to be integrated with automated liquid handling platforms, workflows can be effectively streamlined for efficient high-throughput experimentation.”

Thermo Fisher Scientific Inc. 

 


Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE